Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting

SAN DIEGO, Nov. 13, 2023 -- Gyre Therapeutics , a clinical-stage biotechnology company developing anti-fibrotic therapeutics for a variety of chronic liver diseases, today announced the...

Related Keywords

Boston ,Massachusetts ,United States ,Beijing ,China ,San Diego ,California ,Shanghai ,Stephen Jasper ,Charles Wu ,Xianjun Xu ,Department Of Gastroenterology ,Catalyst Biosciences Inc ,Continent Pharmaceuticals Ltd ,Medicines Product Administration Of China ,Shanghai Jiao Tong University School Of Medicine ,American Association ,Liver Disease ,Pannual Liver Meeting ,Metabolic Dysfunction Associated Steatohepatitis ,Chief Executive Officer ,Tumor Growth Transforming ,Shanghai General Hospital ,Shanghai Jiao Tong University School ,Poster Hall ,Nonalcoholic Steatohepatitis ,New Medicines Product Administration ,Beijing Continent Pharmaceuticals Ltd ,Private Securities Litigation Reform Act ,Catalyst Biosciences ,Annual Report ,Markets ,